Fast and reliable lead discovery for HLA binding – Label-free and ultra-high throughput
T-Cell Therapy
Taking lead screening to the next level
BioCopy provides the shortcut to navigate the complexity of the immune system for future tumor and autoimmune therapy. Our cutting-edge microarray technology provides efficient immune profiling and lead screening of T-cell receptors (TCR), bi- and multispecifics, and other biomolecules against thousands of antigen-HLA complexes in parallel.
The complexity and mutagenicity of viral and bacterial pathogens requires a new flexibility and efficiency in the development of vaccines. BioCopy’s technology helps select vaccine candidates very soon after pathogen identification. In this way, vaccines against new pathogens can be developed much faster and more efficiently.
Two cutting edge technologies – two central areas of expertise
Microarrays
Cutting-edge and tailor-made microarrays ready to use for binding kinetic measurement.
We are your experts in the fabrication of microarrays of all kinds. Our spectrum ranges from arrays consisting of DNA spots, protein spots or spots made of biomolecular complexes. We will find the matching solution to analyze the binding kinetic of almost any kind of analyte.
Ultra-high throughput analyses with BioCopy SCORE technology
BioCopy’s Single COlor Reflectometry (SCORE) enables the ultra-high throughput analysis of molecular binding interactions. We evaluate the kinetic parameters of a large amount of different biomolecules fast, label-free and in real-time.
BioCopy patent complex array fabrication process granted much earlier than usual setting new standards in the state of the art for kinetic binding measurement.
